A seasoned leader in the field of ophthalmology, Mr. Clatterbaugh brings over two decades of transformative leadership and strategic vision to his role as Chief of Staff, Ocular Therapeutix. With a proven track record of driving innovation, maximizing operational efficiency, and fostering collaborative environments, Mr. Clatterbaugh is dedicated to shaping the future of ocular healthcare.
Prior to joining Ocular Therapeutix, Mr. Clatterbaugh held various executive roles, including Vice President & Chief of Staff at Iveric Bio as well as leading Iveric Bio’s Launch Strategy and Portfolio & Pipeline Planning, where he spearheaded initiatives to optimize commercial potential and enhance market performance. His expertise extends across multiple facets of the industry, from integrated launch strategies to global portfolio management, market access, marketing, medical affairs, and operations.
Prior to joining Iveric Bio, Mr. Clatterbaugh held key leadership positions at Novartis Pharmaceuticals Corporation and Alcon Laboratories, Inc., where he played instrumental roles in driving growth and expanding market presence. Mr. Clatterbaugh holds a Bachelor of Science in Finance & Marketing Management from Virginia Tech.